Kristian Riesbeck

Title: Kristian Riesbeck: Innovator in Protein Research

Introduction

Kristian Riesbeck is a prominent inventor based in Malmö, Sweden. He has made significant contributions to the field of protein research, holding a total of 15 patents. His work focuses on surface exposed proteins and their applications in immunology and vaccine development.

Latest Patents

One of his latest patents involves a surface exposed protein known as protein E (pE). This invention relates to a virulence factor that can be detected and has an amino acid sequence as described in SEQ ID NO 1. The patent also covers an immunogenic fragment of this protein, as well as a recombinant immunogenic protein (pE(A)) and its truncated variants. Additionally, it describes nucleic acid sequences, vaccines, plasmids, phages, non-human hosts, recombinant nucleic acid sequences, fusion proteins, and fusion products. Another significant patent discusses the interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins, and the complement system. This disclosure highlights the ability of surface proteins to interact with epithelial cells via cell-associated fibronectin and laminin, and their role in inhibiting the complement system, making them useful in vaccine preparation.

Career Highlights

Throughout his career, Kristian has worked with notable companies, including Arne Forsgren AB and Arne Forsgren et al. His innovative research has positioned him as a key figure in the field of protein science.

Collaborations

Kristian has collaborated with esteemed colleagues such as Arne Forsgren and Anthony Dorling, further enhancing the impact of his research.

Conclusion

Kristian Riesbeck's contributions to protein research and vaccine development are noteworthy. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge in this critical area.